Literature DB >> 16011701

Adjusting O'Brien's test to control type I error for the generalized nonparametric Behrens-Fisher problem.

Peng Huang1, Barbara C Tilley, Robert F Woolson, Stuart Lipsitz.   

Abstract

O'Brien (1984, Biometrics 40, 1079-1087) introduced a simple nonparametric test procedure for testing whether multiple outcomes in one treatment group have consistently larger values than outcomes in the other treatment group. We first explore the theoretical properties of O'Brien's test. We then extend it to the general nonparametric Behrens-Fisher hypothesis problem when no assumption is made regarding the shape of the distributions. We provide conditions when O'Brien's test controls its error probability asymptotically and when it fails. We also provide adjusted tests when the conditions do not hold. Throughout this article, we do not assume that all outcomes are continuous. Simulations are performed to compare the adjusted tests to O'Brien's test. The difference is also illustrated using data from a Parkinson's disease clinical trial.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16011701      PMCID: PMC2827210          DOI: 10.1111/j.1541-0420.2005.00322.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  10 in total

1.  Closed testing procedures for group sequential clinical trials with multiple endpoints.

Authors:  D I Tang; N L Geller
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results.

Authors:  D K Li; G J Zhao; D W Paty
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

3.  The analysis of multiple endpoints in clinical trials.

Authors:  S J Pocock; N L Geller; A A Tsiatis
Journal:  Biometrics       Date:  1987-09       Impact factor: 2.571

4.  On the design and analysis of randomized clinical trials with multiple endpoints.

Authors:  D I Tang; N L Geller; S J Pocock
Journal:  Biometrics       Date:  1993-03       Impact factor: 2.571

5.  Global tests for multiple binary outcomes.

Authors:  M Lefkopoulou; L Ryan
Journal:  Biometrics       Date:  1993-12       Impact factor: 2.571

6.  Procedures for comparing samples with multiple endpoints.

Authors:  P C O'Brien
Journal:  Biometrics       Date:  1984-12       Impact factor: 2.571

7.  Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

Authors:  Clifford W Shults; David Oakes; Karl Kieburtz; M Flint Beal; Richard Haas; Sandy Plumb; Jorge L Juncos; John Nutt; Ira Shoulson; Julie Carter; Katie Kompoliti; Joel S Perlmutter; Stephen Reich; Matthew Stern; Ray L Watts; Roger Kurlan; Eric Molho; Madaline Harrison; Mark Lew
Journal:  Arch Neurol       Date:  2002-10

8.  Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group.

Authors:  B C Tilley; S R Pillemer; S P Heyse; S Li; D O Clegg; G S Alarcón
Journal:  Arthritis Rheum       Date:  1999-09

9.  Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.

Authors:  K D Kaufman; E A Olsen; D Whiting; R Savin; R DeVillez; W Bergfeld; V H Price; D Van Neste; J L Roberts; M Hordinsky; J Shapiro; B Binkowitz; G J Gormley
Journal:  J Am Acad Dermatol       Date:  1998-10       Impact factor: 11.527

10.  Clinical differences among women with and without self-reported perimenstrual asthma.

Authors:  R S Shames; D C Heilbron; S L Janson; J L Kishiyama; D S Au; D C Adelman
Journal:  Ann Allergy Asthma Immunol       Date:  1998-07       Impact factor: 6.347

  10 in total
  19 in total

1.  Basal-like breast cancer displays distinct patterns of promoter methylation.

Authors:  Ji Shin Lee; Mary Jo Fackler; Jae Hyuk Lee; Chan Choi; Min Ho Park; Jung Han Yoon; Zhe Zhang; Saraswati Sukumar
Journal:  Cancer Biol Ther       Date:  2010-06-18       Impact factor: 4.742

2.  Robust Bayesian hierarchical model using normal/independent distributions.

Authors:  Geng Chen; Sheng Luo
Journal:  Biom J       Date:  2015-12-29       Impact factor: 2.207

3.  Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.

Authors:  Karl Kieburtz; Barbara C Tilley; Jordan J Elm; Debra Babcock; Robert Hauser; G Webster Ross; Alicia H Augustine; Erika U Augustine; Michael J Aminoff; Ivan G Bodis-Wollner; James Boyd; Franca Cambi; Kelvin Chou; Chadwick W Christine; Michelle Cines; Nabila Dahodwala; Lorelei Derwent; Richard B Dewey; Katherine Hawthorne; David J Houghton; Cornelia Kamp; Maureen Leehey; Mark F Lew; Grace S Lin Liang; Sheng T Luo; Zoltan Mari; John C Morgan; Sotirios Parashos; Adriana Pérez; Helen Petrovitch; Suja Rajan; Sue Reichwein; Jessie Tatsuno Roth; Jay S Schneider; Kathleen M Shannon; David K Simon; Tanya Simuni; Carlos Singer; Lewis Sudarsky; Caroline M Tanner; Chizoba C Umeh; Karen Williams; Anne-Marie Wills
Journal:  JAMA       Date:  2015-02-10       Impact factor: 56.272

4.  Nonparametric bayes testing of changes in a response distribution with an ordinal predictor.

Authors:  Michael L Pennell; David B Dunson
Journal:  Biometrics       Date:  2007-08-30       Impact factor: 2.571

5.  A Bayesian approach to joint analysis of multivariate longitudinal data and parametric accelerated failure time.

Authors:  Sheng Luo
Journal:  Stat Med       Date:  2013-09-06       Impact factor: 2.373

6.  A rank test for bivariate time-to-event outcomes when one event is a surrogate.

Authors:  Pamela A Shaw; Michael P Fay
Journal:  Stat Med       Date:  2016-04-05       Impact factor: 2.373

7.  A Rank-Based Test for Comparison of Multidimensional Outcomes.

Authors:  Aiyi Liu; Qizhai Li; Chunling Liu; Kai Yu; Kai F Yu
Journal:  J Am Stat Assoc       Date:  2010-06-01       Impact factor: 5.033

8.  Using global statistical tests in long-term Parkinson's disease clinical trials.

Authors:  Peng Huang; Christopher G Goetz; Robert F Woolson; Barbara Tilley; Douglas Kerr; Yuko Palesch; Jordan Elm; Bernard Ravina; Kenneth J Bergmann; Karl Kieburtz
Journal:  Mov Disord       Date:  2009-09-15       Impact factor: 10.338

9.  Bayesian multiple imputation for missing multivariate longitudinal data from a Parkinson's disease clinical trial.

Authors:  Sheng Luo; Andrew B Lawson; Bo He; Jordan J Elm; Barbara C Tilley
Journal:  Stat Methods Med Res       Date:  2012-12-12       Impact factor: 3.021

10.  Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.

Authors:  Jordan J Elm
Journal:  Mov Disord       Date:  2012-10       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.